Durvalumab vs Lamotrigine

## Durvalumab vs Lamotrigine: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Lamotrigine**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Lamotrigine**: Sodium channel blocker inhibiting glutamate release.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Lamotrigine — 25 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Lamotrigine — C9H7Cl2N5.

**Molecular Weight**: Durvalumab — N/A; Lamotrigine — 256.0910 g/mol.

**Type**: Durvalumab — Antibody; Lamotrigine — Small molecule.